CSCO Financial Statements & Analysis
Complete financial statements for CSCO including income statement, balance sheet, and cash flow statement. Analyze CSCO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
61
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
5.3% ↑
Net Income
1.3% ↑
Gross Margin
-1.3% ↓
Operating Margin
0.8% ↑
Balance Sheet
Current Ratio
11.0% ↑
Debt to Equity
-12.5% ↑
Asset Turnover
6.9% ↑
Cash Flow
Operating Cash Flow
30.5% ↑
Net Cash Flow
75.7% ↑
Free Cash Flow
30.1% ↑
Cash Flow to Debt
43.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 53.80B | 56.65B | 5.3% | |
| Gross Profit | 34.83B | 36.18B | 3.9% | |
| Operating Income | 12.18B | 12.93B | 6.1% | |
| Net Income | 10.32B | 10.45B | 1.3% | |
| EPS | 2.55 | 2.63 | 3.1% | |
| EBITDA | 15.75B | 15.86B | 0.7% | |
| Gross Margin | 64.73% | 63.87% | 1.3% | |
| Operating Margin | 22.64% | 22.81% | 0.8% | |
| Net Income Margin | 19.18% | 18.45% | 3.8% | |
| R&D Expenses | 7.98B | 9.30B | 16.5% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 56.65B | 53.80B | 57.00B | 51.56B | 49.82B |
| Gross Profit | 36.18B | 34.83B | 35.75B | 32.25B | 31.89B |
| Operating Income | 12.93B | 12.18B | 15.03B | 13.97B | 12.83B |
| Net Income | 10.45B | 10.32B | 12.61B | 11.81B | 10.59B |
| EPS | 2.63 | 2.55 | 3.08 | 2.83 | 2.51 |
| EBITDA | 15.86B | 15.75B | 17.47B | 16.79B | 15.56B |
| Gross Margin | 63.87% | 64.73% | 62.73% | 62.55% | 64.02% |
| Operating Margin | 22.81% | 22.64% | 26.37% | 27.09% | 25.76% |
| Net Income Margin | 18.45% | 19.18% | 22.13% | 22.91% | 21.26% |
| R&D Expenses | 9.30B | 7.98B | 7.55B | 6.77B | 6.55B |